Abingworth’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$822K	Hold	131,036	–	–	0.27%	15
2022 Q3	$457K	Hold	131,036	–	–	0.16%	15
2022 Q2	$385K	Hold	131,036	–	–	0.12%	17
2022 Q1	$406K	Hold	131,036	–	–	0.12%	18
2021 Q4	$442K	Hold	131,036	–	–	0.11%	18
2021 Q3	$478K	Hold	131,036	–	–	0.11%	18
2021 Q2	$571K	Hold	131,036	–	–	0.18%	17
2021 Q1	$595K	Hold	131,036	–	–	0.21%	15
2020 Q4	$752K	Hold	131,036	–	–	0.26%	13
2020 Q3	$947K	Hold	131,036	–	–	0.2%	14
2020 Q2	$456K	Hold	131,036	–	–	0.13%	15
2020 Q1	$191K	Hold	131,036	–	–	0.13%	15
2019 Q4	$256K	Hold	131,036	–	–	0.12%	14
2019 Q3	$670K	Hold	131,036	–	–	0.42%	11
2019 Q2	$937K	Hold	131,036	–	–	0.36%	11
2019 Q1	$1.74M	Hold	131,036	–	–	1.56%	10
2018 Q4	$1.03M	Sell	131,036 -142,381	-52%	-$1.12M	0.94%	14
2018 Q3	$3.03M	Hold	273,417	–	–	1.8%	9
2018 Q2	$3.67M	Hold	273,417	–	–	2.09%	8
2018 Q1	$3.55M	Sell	273,417 -873,660	-76%	-$11.3M	2.21%	7
2017 Q4	$10.6M	Sell	1,147,077 -395,645	-26%	-$3.64M	7.65%	4
2017 Q3	$12.4M	Sell	1,542,722 -57,278	-4%	-$461K	8.6%	4
2017 Q2	$9.22M	Hold	1,600,000	–	–	7.33%	4
2017 Q1	$6.86M	Hold	1,600,000	–	–	5.11%	4
2016 Q4	$2.72M	Hold	1,600,000	–	–	2.27%	7
2016 Q3	$3.1M	Hold	1,600,000	–	–	2.98%	10
2016 Q2	$2.8M	Hold	1,600,000	–	–	2.93%	10
2016 Q1	$2.16M	Hold	1,600,000	–	–	2.01%	12
2015 Q4	$2.67M	Hold	1,600,000	–	–	1.61%	13
2015 Q3	$3.07M	Buy	+1,600,000	New	+$3.07M	1.79%	10